State Street Health Care Select Sector SPDR ETF
No enriched coverage for $XLV in the last 7 days.
State Street Health Care Select Sector SPDR ETF (XLV) sold $320.2 million in assets on Nov. 9, reducing positions in all 60 holdings. Largest sales included Eli Lilly (LLY) at $53.1 million, Johnson & Johnson (JNJ) at $31.9 million, and AbbVie (ABBV) at $24.4 million. XLV manages $50.54 billion in assets with a 0.08% expense ratio.
State Street Health Care Select Sector SPDR ETF (XLV) bought $330.3M in stocks on Nov. 3, increasing all 60 holdings. Top purchases included Eli Lilly (LLY) at $56.0M, Johnson & Johnson (JNJ) at $31.8M, and AbbVie (ABBV) at $25.1M. XLV has $49.13B in assets and a 0.08% expense ratio.
State Street Health Care Select Sector SPDR ETF (XLV) bought $134.4 million in stocks on Tuesday, increasing positions in 60 holdings. The largest purchases were in Eli Lilly (LLY) at $21.2 million, Johnson & Johnson (JNJ) at $13.4 million, and AbbVie (ABBV) at $10.5 million. XLV holds 60 stocks, with top holdings including LLY, JNJ, ABBV, UnitedHealth (UNH), and Merck (MRK).
Recent XLV coverage spans financial news and sector analysis.
State Street Health Care Select Sector SPDR ETF (XLV) sold $320.2 million in assets on Nov. 9, reducing positions in all 60 holdings. Largest sales included Eli Lilly (LLY) at $53.1 million, Johnson & Johnson (JNJ) at $31.9 million, and AbbVie (ABBV) at $24.4 million. XLV manages $50.54 billion in assets with a 0.08% expense ratio.
State Street Health Care Select Sector SPDR ETF (XLV) bought $330.3M in stocks on Nov. 3, increasing all 60 holdings. Top purchases included Eli Lilly (LLY) at $56.0M, Johnson & Johnson (JNJ) at $31.8M, and AbbVie (ABBV) at $25.1M. XLV has $49.13B in assets and a 0.08% expense ratio.
State Street Health Care Select Sector SPDR ETF (XLV) bought $134.4 million in stocks on Tuesday, increasing positions in 60 holdings. The largest purchases were in Eli Lilly (LLY) at $21.2 million, Johnson & Johnson (JNJ) at $13.4 million, and AbbVie (ABBV) at $10.5 million. XLV holds 60 stocks, with top holdings including LLY, JNJ, ABBV, UnitedHealth (UNH), and Merck (MRK).
Fund activity shows broad de-risking within the healthcare ETF for that day, which can pressure near-term flows and sentiment for its largest constituents.
State Street Health Care Select Sector SPDR ETF (XLV) added positions in Eli Lilly (LLY), Johnson & Johnson (JNJ), and AbbVie (ABBV) on Oct. 15, with purchases totaling $48.4M, $29.5M, and $24.2M respectively. XLV's portfolio remains entirely in healthcare equities, with a 15.57% YTD return and a 1.44% dividend yield.
AlphAI scores every news story that mentions XLV with an AI model for sentiment and relevance, and aggregates insider trades from State Street Health Care Select Sector SPDR ETF's SEC EDGAR Form 4 filings. Figures refresh continuously.
State Street Health Care Select Sector SPDR ETF (XLV) sold $320.2 million in assets on Nov. 9, reducing positions in all 60 holdings. Largest sales included Eli Lilly (LLY) at $53.1 million, Johnson & Johnson (JNJ) at $31.9 million, and AbbVie (ABBV) at $24.4 million. XLV manages $50.54 billion in assets with a 0.08% expense ratio.
State Street Health Care Select Sector SPDR ETF (XLV) bought $330.3M in stocks on Nov. 3, increasing all 60 holdings. Top purchases included Eli Lilly (LLY) at $56.0M, Johnson & Johnson (JNJ) at $31.8M, and AbbVie (ABBV) at $25.1M. XLV has $49.13B in assets and a 0.08% expense ratio.
State Street Health Care Select Sector SPDR ETF (XLV) bought $134.4 million in stocks on Tuesday, increasing positions in 60 holdings. The largest purchases were in Eli Lilly (LLY) at $21.2 million, Johnson & Johnson (JNJ) at $13.4 million, and AbbVie (ABBV) at $10.5 million. XLV holds 60 stocks, with top holdings including LLY, JNJ, ABBV, UnitedHealth (UNH), and Merck (MRK).
State Street Health Care Select Sector SPDR ETF (XLV) sold $172.2M in assets on Oct. 22, reducing positions in 60 holdings. Largest sales were Eli Lilly (LLY) at $27.4M, Johnson & Johnson (JNJ) at $16.9M, and AbbVie (ABBV) at $13.2M. XLV's portfolio is valued at $46.98B with a 18.71% YTD return.
State Street Health Care Select Sector SPDR ETF (XLV) added positions in Eli Lilly (LLY), Johnson & Johnson (JNJ), and AbbVie (ABBV) on Oct. 15, with purchases totaling $48.4M, $29.5M, and $24.2M respectively. XLV's portfolio remains entirely in healthcare equities, with a 15.57% YTD return and a 1.44% dividend yield.
The Nasdaq fell over 1% as AI-related stocks declined. RBC Capital Markets shifted sector allocations, upgrading health care and downgrading technology. Semtech (SMTC) saw mixed analyst actions, Klaviyo (KVYO) was downgraded, and Manhattan Associates (MANH) received split views. The S&P 500 is down 1.13% today and 2.02% this week, trading at 7,656.89.
AI stocks faced volatility, prompting capital rotation into pharmaceuticals. Eli Lilly (LLY) and AbbVie (ABBV) neared record highs, with LLY at $1,251.61 and ABBV at $283.40. Healthcare ETF XLV hit $177.19. LLY's gains were driven by its GLP-1 dominance and M&A activity, while ABBV's rally followed positive Skyrizi data. Other large-cap pharma stocks also rose, but biotech ETF XBI declined 2.8% over a month.
The article compares healthcare ETFs XLV (State Street Health Care Select Sector SPDR) and FHLC (Fidelity MSCI Health Care Index). XLV holds about 60 S&P 500 healthcare stocks, with over 25% concentrated in Eli Lilly and Johnson & Johnson, making results dependent on those firms. FHLC holds 300+ stocks, including mid/small caps, offering broader diversification but higher volatility, according to the article.
